CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…
PITTSBURGH, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on…
BOTHELL, Wash., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing…
Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to strengthen IMPLANET’s equity capital and…
FendX Technologies Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation…
Revenue of €4.3 million in the first half of 2023, +4% compared with H1 2022 Continued dynamic R&D investment coupled…
LONDON, UK / ACCESSWIRE / September 28, 2023 / Genflow (LSE:GENF) is pleased to announce its half year results for…
HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress…
Calgary, Alberta--(Newsfile Corp. - September 27, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce…
SEBASTIAN, FL / ACCESSWIRE / September 27, 2023 / Addiction Helpline America, a no-cost to consumer drug and alcohol treatment…